Precision Therapy in KCNQ2-Related Epilepsy-Reference-Cited by-同舟云学术

Precision Therapy in KCNQ2-Related Epilepsy

Published:2023-09-18 Issue:05 Volume:54 Page:295-296
ISSN:0174-304X
Container-title:Neuropediatrics
language:en
Short-container-title:Neuropediatrics

Author:

Borggraefe Ingo¹²,Wagner Matias¹³

Affiliation:

1. Department of Pediatrics, Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig Maximilian University Munich, Munich, Germany

2. Comprehensive Epilepsy Center for Children and Adolescents, University Hospital, Ludwig Maximilians University Munich, Munich, Germany

3. Institute of Neurogenomics, Helmholtz Centrum, Munich, Germany

Publisher

Georg Thieme Verlag KG

Subject

Neurology (clinical),General Medicine,Pediatrics, Perinatology and Child Health

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0043-1772667.pdf

Reference7 articles.

1. Antiepileptic therapy approaches in KCNQ2 related epilepsy: a systematic review;M Kuersten;Eur J Med Genet,2020

2. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy;G Orhan;Ann Neurol,2014

3. KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients;J J Millichap;Neurol Genet,2016

4. Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy;D Knight;Epilepsia,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations;Epilepsia Open;2024-08-14

2. Clinical features of developmental and epileptic encephalopathy caused by <i>KCNQ2</i> gene mutation;Epilepsy and paroxysmal conditions;2023-12-22